BridgeMD
New treatment option for Gait, Hemiplegic
Official title Gait Analysis in Patients With Hemiplegia Using Insole Splint.
ClinicalTrials.gov ID: NCT05908149
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the gait of patients with hemiplegia, with or without the use of insole splint. The main questions it aims to answer are: Does the insole splint improve the gait of these patients?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Patients that can walk with or without the splint, having their first stroke episode at least two months ago and their hospitalisation period does...
- Patients must have use the insole splint during physiotherapy sessions for at least 1 week before their inclusion in the trial.
- Patients must be able to communicate and fully understand the instructions given by the researchers.
- Researchers are going to try to have a sex ratio 50/50.
- Patients' age is going to be between 18-70 years.
You likely can't join if
- Peripheral Neurological Damage.
- Past or ongoing orthopedic or reumatologic disease that bothers patient's gait.
- Past damage of the Central Nervous System.
- Dermatologic problems or human factors that limitate the use of insole splint.
- Patients must not have used intramuscular botox injection recently.
- Patients with low motivation and low perception are also excluded.
See the full eligibility criteria
- Patients that can walk with or without the splint, having their first stroke episode at least two months ago and their hospitalisation period does not overcome six months, having also a diagnosis from a neurologist...
- Patients must have use the insole splint during physiotherapy sessions for at least 1 week before their inclusion in the trial.
- Patients must be able to communicate and fully understand the instructions given by the researchers.
- Researchers are going to try to have a sex ratio 50/50.
- Patients' age is going to be between 18-70 years.
- Functional Ambulation Category: FAC \> 2
- Modified Ashworth Scale of the affected lower Limb (MAS): MAS ≤2
- Normal Gait before the stroke.
- Peripheral Neurological Damage.
- Past or ongoing orthopedic or reumatologic disease that bothers patient's gait.
- Past damage of the Central Nervous System.
- Dermatologic problems or human factors that limitate the use of insole splint.
- Patients must not have used intramuscular botox injection recently.
- Patients with low motivation and low perception are also excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Ioannina, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ioannina, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.